Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 3Urinary Bladder Neoplasms 1Stomach Neoplasms 1Prostatic Neoplasms 1Lymphatic Metastasis 1High-Risk Cancer 1Carcinoma, Squamous Cell 1Breast Neoplasms 1

Interventions

Surgical Procedures, Operative 3Indocyanine Green 3TP protocol 2Radiotherapy 2Chemotherapy, Adjuvant 2Sentinel Lymph Node Biopsy 1Radiotherapy, Adjuvant 1Radiosurgery 1Positron-Emission Tomography 1Paclitaxel 1PITX2 protein, human 1Magnetic Resonance Imaging 1Lymph Node Excision 1Injections 1Gastroscopy 1Fluorescence 1Endoscopic Ultrasound-Guided Fine Needle Aspiration 1Control Groups 1Cobalt-60 1Cisplatin 1Chemoradiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Lymphatic Metastasis × Radiotherapy, Adjuvant × Clear all
NCT02891083 2016-09-07

Adjuvant Therapies or Surgery Alone for High Risk pN0 Esophageal Cancer

Shanghai Chest Hospital

Phase 3 Unknown
486 enrolled
Gastrointestinal

Carcinoma, Squamous Cell, Esophageal Neoplasms, Lymphatic Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡